ArticlePharmaceutics2021

Targeted RNAi of BIRC5/Survivin Using Antibody-Conjugated Poly(Propylene Imine)-Based Polyplexes Inhibits Growth of PSCA-Positive Tumors.

Willi Jugel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.